Eagle Pharmaceuticals (EGRX) Tops Q2 EPS by 15c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
Eagle Pharmaceuticals (EGRX) PT Raised to $84 at RBC Capital
August 8, 2018 8:32 AM EDTRBC Capital raised its price target on Eagle Pharmaceuticals (NASDAQ: EGRX) to $84.00 (from $74.00) while maintaining a Outperform rating.
... More